MiRagen Therapeutics, Signal Genetics sign merger agreement

MiRagen Therapeutics, Signal Genetics sign merger agreement

BOULDER --Miragen Therapeutics and California-based Signal Genetics, Inc. (Nasdaq: SGNL) today announced they have entered into a definitive merger agreement in which the stockholders of miRagen... Read More

Tuesday November 1, 2016 0 comments Tags: miRagen Therapeutics, Signal Genetics, William S. Marshall, Samuel D. Riccitelli